IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 322 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $275,332 | -35.4% | 5,777 | -41.2% | 0.00% | -33.3% |
Q1 2024 | $425,957 | -20.2% | 9,826 | -6.9% | 0.01% | -14.3% |
Q4 2023 | $533,674 | +7.3% | 10,549 | -3.8% | 0.01% | -12.5% |
Q3 2023 | $497,508 | +10.0% | 10,968 | -0.5% | 0.01% | +14.3% |
Q2 2023 | $452,110 | +14.4% | 11,019 | -0.3% | 0.01% | +16.7% |
Q1 2023 | $395,105 | +0.9% | 11,055 | +6.6% | 0.01% | 0.0% |
Q4 2022 | $391,637 | -18.2% | 10,369 | -4.3% | 0.01% | -25.0% |
Q3 2022 | $479,000 | +18.9% | 10,834 | -0.6% | 0.01% | +14.3% |
Q2 2022 | $403,000 | -1.0% | 10,903 | -0.8% | 0.01% | +16.7% |
Q1 2022 | $407,000 | +37.0% | 10,995 | +12.4% | 0.01% | +50.0% |
Q4 2021 | $297,000 | -18.6% | 9,782 | -10.1% | 0.00% | -20.0% |
Q3 2021 | $365,000 | -14.5% | 10,882 | +1.5% | 0.01% | -16.7% |
Q2 2021 | $427,000 | -13.0% | 10,717 | -2.0% | 0.01% | -25.0% |
Q1 2021 | $491,000 | -14.9% | 10,936 | +7.3% | 0.01% | -20.0% |
Q4 2020 | $577,000 | +7.9% | 10,190 | -9.6% | 0.01% | 0.0% |
Q3 2020 | $535,000 | -24.1% | 11,276 | -5.6% | 0.01% | -33.3% |
Q2 2020 | $705,000 | +22.2% | 11,947 | -2.3% | 0.02% | +7.1% |
Q1 2020 | $577,000 | -24.6% | 12,223 | -3.5% | 0.01% | -12.5% |
Q4 2019 | $765,000 | -1.5% | 12,663 | -2.4% | 0.02% | -5.9% |
Q3 2019 | $777,000 | -12.5% | 12,968 | -6.1% | 0.02% | -15.0% |
Q2 2019 | $888,000 | -25.1% | 13,813 | -5.4% | 0.02% | -25.9% |
Q1 2019 | $1,185,000 | +48.1% | 14,600 | -1.3% | 0.03% | +35.0% |
Q4 2018 | $800,000 | +2.4% | 14,793 | -2.3% | 0.02% | +17.6% |
Q3 2018 | $781,000 | -13.7% | 15,139 | -30.3% | 0.02% | -22.7% |
Q2 2018 | $905,000 | -10.5% | 21,734 | -5.2% | 0.02% | -12.0% |
Q1 2018 | $1,011,000 | -10.0% | 22,938 | +3.6% | 0.02% | -16.7% |
Q4 2017 | $1,123,000 | 0.0% | 22,134 | 0.0% | 0.03% | +3.4% |
Q3 2017 | $1,123,000 | +2.7% | 22,134 | +2.9% | 0.03% | -3.3% |
Q2 2017 | $1,094,000 | +19.0% | 21,502 | -6.0% | 0.03% | +15.4% |
Q1 2017 | $919,000 | – | 22,869 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |